Ampk Activator

• US 20070244202A1
• Filed: 06/21/2005
• Published: 10/18/2007
• Est. Priority Date: 06/28/2004
• Status: Abandoned Application

• Current Assignee: KAO Corporation
• Original Assignee: KAO Corporation
• Inventors: Murase, Takatoshi
• Application Number:
  US11/629,486
• Publication Number:
  US 20070244202A1
• Time in Patent Office: Days
• US Class Current: 514/734
• CPC Class Codes: A23L 33/105 Plant extracts, their artificial duplicates or their derivatives
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/05 Phenols cannabinoids A61K31/658
• CPC Class Codes: A61K 36/752 Citrus, e.g. lime, orange or lemon
• CPC Class Codes: A61P 1/16 for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
• CPC Class Codes: A61P 3/04 Anorexiants; Antiobesity agents
• CPC Class Codes: A61P 3/06 Antihyperlipidemics
• CPC Class Codes: A61P 3/10 for hyperglycaemia, e.g. antidiabetics
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The present invention relates to an AMPK activator containing resveratrol as an active ingredient. The present invention provides an AMPK activator containing, as an active ingredient, an ingredient contained in a naturally occurring material which has been consumed as a food or beverage for a long period of time, which exhibits high safety, which is readily available, which exhibits excellent processability, and which can be employed practically in humans.

Claims

1. An AMPK activator comprising resveratrol as an active ingredient.

2. A lipid metabolism activating agent comprising resveratrol as an active ingredient.

3. An obesity suppressing agent comprising resveratrol as an active ingredient.

4. A diabetes preventing/ameliorating agent comprising resveratrol as an active ingredient.

5. A hepatic hypertrophy suppressing agent comprising resveratrol as an active ingredient.

6. A fatty liver suppressing agent comprising resveratrol as an active ingredient.

7. A food or beverage comprising resveratrol, and exhibiting the effect of preventing or ameliorating obesity and/or body fat accumulation and/or diabetes and/or fatty liver and/or a lifestyle-related disease, wherein the food or beverage is indicated by a label to be used for such effect.

8. A food or beverage comprising resveratrol, and exhibiting the effect of promoting lipid metabolism, wherein the food or beverage is indicated by a label to be used for such effect.

9. An exercise-substitutive agent comprising resveratrol as an active ingredient.

10. A food or beverage characterized by comprising resveratrol and exhibiting an exercise-substitutive function, wherein the food or beverage is indicated by a label to be used for such effect.

11. Use of resveratrol for producing an AMPK activator.

12. Use of resveratrol for producing a lipid metabolism activating agent.

13. Use of resveratrol for producing an obesity suppressing agent.

14. Use of resveratrol for producing a diabetes preventing/ameliorating agent.

15. Use of resveratrol for producing a hepatic hypertrophy suppressing agent.

16. Use of resveratrol for producing a fatty liver suppressing agent.

17. Use of resveratrol for producing an exercise-substitutive agent.

18. A method for activating AMPK, characterized by comprising administration of an effective amount of resveratrol.

19. A method for activating lipid metabolism, characterized by comprising administration of an effective amount of resveratrol.

20. A method for suppressing obesity, characterized by comprising administration of an effective amount of resveratrol.

21. A method for preventing or ameliorating diabetes, characterized by comprising administration of an effective amount of resveratrol.

22. A method for suppressing hepatic hypertrophy, which comprises administration of an effective amount of resveratrol.

23. A method for suppressing fatty liver, which comprises administration of an effective amount of resveratrol.

24. An exercise-substitutive method comprising administration of an effective amount of resveratrol.